These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36274500)

  • 1. MicroRNA-501-3p targeting TM4SF1 facilitates tumor-related behaviors of gastric cancer cells via EMT signaling pathway.
    Wei Y; Yin L; Xie X; Wu Z; Zhang J; Gao Y; Tang J
    Mutat Res; 2022; 825():111802. PubMed ID: 36274500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect and mechanism of downregulating the long-chain noncoding RNA TM4SF1-AS1 on the proliferation, apoptosis and invasion of gastric cancer cells.
    He C; Qi W; Wang Z
    World J Surg Oncol; 2021 Jul; 19(1):226. PubMed ID: 34330293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.
    Park YR; Kim SL; Lee MR; Seo SY; Lee JH; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1915-1927. PubMed ID: 28528497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.
    Liu H; Chen Y; Zhou L; Jiang X; Zhou X
    Bioengineered; 2022 Apr; 13(4):9613-9627. PubMed ID: 35412956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.
    Li D; Li Q
    Bioengineered; 2022 Mar; 13(3):6509-6520. PubMed ID: 35226830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
    Zhang M; Wang S; Yi A; Qiao Y
    Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.
    Lei H; Zou D; Li Z; Luo M; Dong L; Wang B; Yin H; Ma Y; Liu C; Wang F; Zhang J; Yu J; Li Y
    PLoS One; 2013; 8(4):e60369. PubMed ID: 23637748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
    Liu L; Tian YC; Mao G; Zhang YG; Han L
    Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
    Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
    Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
    Chen XB; Li W; Chu AX
    J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision hyperthermia-induced miRNA-409-3p upregulation inhibits migration, invasion, and EMT of gastric cancer cells by targeting KLF17.
    Feng J; Li K; Liu G; Feng Y; Shi H; Zhang X
    Biochem Biophys Res Commun; 2021 Apr; 549():113-119. PubMed ID: 33667708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer.
    Huang L; Zhang X; Li F; Wang X
    Comput Math Methods Med; 2022; 2022():2880087. PubMed ID: 35126619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.